LCD Reference Article Billing and Coding Article

Billing and Coding: Hemophilia Factor Products

A56482

Expand All | Collapse All
Draft Article
Draft Articles are works in progress and not necessarily a reflection of the current billing and coding practices. Revisions to codes are carefully and thoroughly reviewed and are not intended to change the original intent of the LCD.
NOT AN LCD REFERENCE ARTICLE
This article is not in direct support of an LCD.

Document Note

Note History

Contractor Information

Article Information

General Information

Source Article ID
N/A
Article ID
A56482
Original ICD-9 Article ID
Not Applicable
Article Title
Billing and Coding: Hemophilia Factor Products
Article Type
Billing and Coding
Original Effective Date
01/08/2019
Revision Effective Date
10/01/2023
Revision Ending Date
N/A
Retirement Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

CMS National Coverage Policy

Internet-Only Manuals (IOMs):

  • CMS IOM Publication 100-04, Medicare Claims Processing Manual,
    • Chapter 17, Section 80.4 Billing for Hemophilia Clotting Factors, Section 80.4.1 Clotting Factor Furnishing Fee

Social Security Act (Title XVIII) Standard References:

  • Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period.

Article Guidance

Article Text

This Billing and Coding Article provides coding guidance for Hemophilia Factor Products.

Coding Guidance

Notice: It is not appropriate to bill Medicare for services that are not covered as if they are covered. When billing for non-covered services, use the appropriate modifier.

The Centers for Medicare & Medicaid Services (CMS) provided CR4229 to clarify billing practices for providers to ensure that units of service for blood clotting factor are reported accurately. Some Medicare providers have been billing units of drugs and biologicals incorrectly on outpatient bills as well as on inpatient claims for hemophilia clotting factors. The erroneous reporting of units of service has resulted in Medicare overpayments (reference Medicare Learning Network [MLN] Matters Number: 4229).

General Billing Instructions

The provider determines the dosage of hemophilia factor furnished to the beneficiary and using the definition of the appropriate HCPCS code, translates the dosage into units of service(s). See example below on translating the dosage administered into ‘units of service’.

Note: Not all short version descriptions of HCPCS codes define units for the HCPCS code. Providers are reminded to refer to the long descriptors of the HCPCS codes in their HCPCS book.

When submitting claims for hemophilia clotting factors it is essential to submit the correct Quantity Billed (QB) to receive the correct reimbursement. Some of the codes are based on international unit (IU) and some may be per milligram (mg) or microgram (mcg) as specified in the code descriptor. Therefore, the units of service(s) reported should reflect the number of IU, mg, or mcg being administered.

JW and JZ Modifiers

When billing for Part B drugs and biologicals (except those provided under a competitive acquisition program [CAP]), the use of the JW modifier to identify unused drugs or biologicals from single-dose containers or single-use packages that are appropriately discarded is required. The discarded amount shall be billed on a separate claim line using the JW modifier. Providers are required to document the discarded drug or biological in the patient’s medical record.

Any amount wasted must be clearly documented in the medical record and should include the date and time, amount of medication wasted, and the reason for the wastage.

The use of the JZ modifier (attesting that there were no discarded amounts) is required on claims to report there are no discarded amounts of unused drugs or biologicals from single-dose containers or single-use packages.

Claims for drugs separately payable under Medicare Part B from single-dose containers are required to report either the JW or JZ modifier, to identify any discarded amounts or to attest that there are no discarded amounts, respectively.

  • The JW and JZ modifier policy does not apply for drugs that are not separately payable, such as packaged OPPS or ASC drugs, or drugs administered in the FQHC or RHC setting.
  • The JW and JZ modifiers do not apply to drugs assigned status indicator N (Items and Services Packaged into APC Rates) under the OPPS. Similarly, the JW and JZ modifiers do not apply to drugs assigned payment indicator “N1” (ASC).

Example of Translating the Dosage Administered into Units of Service

HCPCS Code

Short Descriptor

Billing Unit

Dosage Administered

Units of Service

J7189

Factor viia

Per mcg (1mcg)

13,365 mcg

13,365

 

The provider would calculate the ‘units of service’ with this equation: 13,365 mcg divided by 1 mcg equals 13,365. Note that the process for calculations based on one IU or one mg is the same as the process for calculations based on one mcg.

After the dosage administered has been translated into the total number of units of service, then the provider determines if multiple claim lines should be billed. See “Role of Medically Unlikely Edits (MUE) in Proper Billing”.

Role of Medically Unlikely Edits (MUE) in Proper Billing

When billing for units of service on the same date of service for the same HCPCS code, MUEs play a role in proper billing and coding. The number of units of service reported on the same date of service for the same HCPCS code cannot have a claim line quantity that exceeds the MUE value for that HCPCS code or that exceeds 9,999 units per claim line.

Refer to the CMS.gov website to verify the MUE for each HCPCS code being billed. The units to bill per claim line can be determined by dividing the total number of ‘units of service’ by the MUE value. However, if this amount is greater than 9,999 then an additional limitation will apply. See examples below.

Billing Instructions when MUE is Less than 9,999 Units Per Line

In the below example, the HCPCS code J7193 has a MUE Value of 4,000 units per line. This is the maximum number of units which can be billed per claim line (as per MUE Adjudication Indicator [MAI]). HCPCS code J7193 appears on the CMS.gov MUE spreadsheet as follows:

HCPCS

MUE Value

MUE Adjudication Indicator (MAI)

MUE Rationale

J7193

4,000

1 Line Edit

Clinical: Data

 

If more than one line needs to be billed on the claim, the repeat service modifier (-76) must be appended to the second and subsequent lines.

Example:

Using the HCPCS code J7193 from above, the MUE Value is 4,000 units per line. If 12,500 IUs were administered to a beneficiary on the same date of service, then the total number of ‘units of service’ would be translated to 12,500 (based on the long descriptor, HCPCS code J7193 is per IU). The minimum number of claim lines to report this amount would be calculated as 4 lines (12,500 ÷ 4,000 = 3.125, requiring 4 lines as shown below).

Line

Date of Service (From - To)

Procedure Code/Modifier

Unit of Service

Billed Amount

1

05 02 2022 - 05 02 2022

J7193

4,000

$4,520.00

2

05 02 2022 - 05 02 2022

J7193-76

4,000

$4,520.00

3

05 02 2022 - 05 02 2022

J7193-76

4,000

$4,520.00

4

05 02 2022 - 05 02 2022

J7193-76

500

$565.00

 

Do not report a date range as the date of service. Indicate date span in the narrative of the claim. If the claim is for a monthly supply of clotting factor distributed to the beneficiary on the date of service, indicate ‘monthly supply’ and the date span in the narrative of the claim or the EDI equivalent. For additional information on reporting DOS, see section below titled “Date of Service (DOS)”.

Billing Instructions when MUE is Greater than 9,999 Units Per Line

Due to system limitations, a maximum of 9,999 units of service may be billed on any one claim line. This limitation is applicable in addition to the established MUE limit for the HCPCS code. If the total number of ‘units of service’ exceeds 9,999 divide the total number of units of service by the maximum number of units that can be billed on a claim line to determine the minimum number of claims lines to bill.

Example:

The MUE for HCPCS code J7192 is 22,000 units per line, which exceeds the system limit of 9,999 units per line. If 22,000 IUs were administered to a beneficiary on the same date of service, then the total number of ‘units of service’ would be translated to 22,000 (based on the long descriptor, HCPCS code J7192 is per IU). The minimum number of claim lines to report this amount would be calculated as 3 lines (22,000 ÷ 9,999 = 2.20, requiring 3 lines as shown below).

Line

Date of Service (From - To)

Procedure Code/Modifier

Unit of Service

Billed Amount

1

05 11 2022 - 05 11 2022

J7192

9,999

$13,489.65

2

05 11 2022 - 05 11 2022

J7192-76

9,999

$13,489.65

3

05 11 2022 - 05 11 2022

J7192-76

2,002

$2,702.70

 

If reporting more than one line, bill all subsequent lines with modifier -76, repeat procedure. Do not report a date range as the date of service. Indicate date span in the narrative of the claim. If the claim is for a monthly supply of clotting factor distributed to the beneficiary on the date of service, indicate ‘monthly supply’ and the date span in the narrative of the claim or the EDI equivalent.

Billing for Not Otherwise Classified (NOC) Codes

When billing NOC codes, enter the drug name, dosage and NDC in the claim narrative or the EDI equivalent. Report the number of units in the quantity billed field as “1”.

Dollar Amount Exceeds $99,999.99

When providing a month supply and the total billed amount exceeds $99,999.99, two claims must be submitted.

When billing two claims, ensure that the total dollar amounts are different on each claim.

Example:

The MUE for HCPCS code J7201 is 9,000 units per line. The beneficiary received 47,865 IUs of Factor IX (J7201) ($2.28 per unit). The billed amount is $109,132.20 for the same date of service. The claims should be billed as shown below.

Claim one:

Total Billed Amount is $99,998.52; total units would be 43,859.

Line

Date of Service (From - To)

Procedure Code/Modifier

Unit of Service

Billed Amount

1

06 01 2022 - 06 01 2022

J7201

9,000

$20,520.00

2

06 01 2022 - 06 01 2022

J7201-76

9,000

$20,520.00

3

06 01 2022 - 06 01 2022

J7201-76

9,000

$20,520.00

4

06 01 2022 - 06 01 2022

J7201-76

9,000

$20,520.00

5

06 01 2022 - 06 01 2022

J7201-76

7,859

$17,918.52

 

Claim two:

Total Billed Amount is $9,133.68; total units would be 4,006.

Line

Date of Service (From - To)

Procedure Code/Modifier

Unit of Service

Billed Amount

1

06 01 2022 - 06 01 2022

J7201-76

4,006

$9,133.68

 

Note: Report a narrative description indicating "monthly billing" as well as the total number of units of service and total charge in item 19 of the 1500 claim form or the EDI equivalent.

Date of Service (DOS)

If the factor product is administered within a facility or "incident to" a physician service, the actual date the drug was administered should be reported as the DOS. If the factor product is being billed by a pharmacy to replenish the beneficiary's home supply, the date of delivery should be used as the DOS on the claim.

Documentation Requirements

  1. All documentation must be maintained in the patient's medical record and made available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.
  3. The submitted medical record must support the use of the selected ICD-10-CM code(s). The submitted CPT/HCPCS code must describe the service performed.
  4. Medical record documentation maintained in the patient’s file must document the condition for which the blood clotting factor is being given.
  5. The name of the factor and the dosage required and/or given must be included in the records.

This information is normally found in the office/progress notes, pharmacy forms, hospital records, and/or treatment notes.

Response To Comments

Number Comment Response
1
N/A

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

CPT/HCPCS Modifiers

Group 1

(2 Codes)
Group 1 Paragraph

N/A

Group 1 Codes
Code Description
JW DRUG AMOUNT DISCARDED/NOT ADMINISTERED TO ANY PATIENT
JZ ZERO DRUG AMOUNT DISCARDED/NOT ADMINISTERED TO ANY PATIENT
N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph

It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted.

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

(1 Code)
Group 1 Paragraph

N/A

Group 1 Codes
Code Description
XX000 Not Applicable
N/A

ICD-10-PCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Additional ICD-10 Information

N/A

Bill Type Codes

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the article should be assumed to apply equally to all claims.

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes.

Code Description

Please accept the License to see the codes.

N/A

Other Coding Information

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Coding Table Information

Excluded CPT/HCPCS Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A N/A
N/A
Non-Excluded CPT/HCPCS Ended Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation
10/01/2023 R11

Article revised and published on 10/05/2023 effective for dates of service on and after 10/01/2023 in response to the October Quarterly HCPCS/CPT Code Updates. The following HCPCS code has been added to the Article: J7214 in the CPT/HCPCS Group 1 Codes. Minor formatting changes have been made. 

07/01/2023 R10

Article revised and published on 07/20/2023 effective for dates of service on and after 07/01/2023 in response to the July Quarterly HCPCS/CPT Code Updates. The following HCPCS code has been added to the Article: J7213 in the CPT/HCPCS Group 1 Codes.

The following HCPCS codes were added to the Article: J7175, J7180, J7181, and J7185 in the CPT/HCPCS Group 1 Codes.

Information regarding the JZ modifier has been added and the section title was changed from ‘Reporting Waste’ to ‘JW and JZ Modifiers’. The information for the JW modifier was revised and the reference to CR 9603 was removed.

The name of the Article was changed to Hemophilia Factor Products.

Added a table with information on the JW and JZ modifiers to the CPT/HCPCS Modifiers section under Group 1 Codes.

10/01/2022 R9

Article revised and published on 11/03/2022 effective for dates of service on and after 10/01/2022.  The reference to LCD L33684 was removed under 'Article Text' due to the LCD being retired effective 10/01/2022.

10/01/2022 R8

Article revised and published on 10/20/2022 effective for dates of service on and after 10/01/2022. The related LCD has been retired. Therefore, all ICD-10-CM Codes that Support Medical Necessity have been removed from the article. Providers should report the most specific ICD-10-CM code that adequately describes the service rendered. Detailed billing instructions have been added to the Article Text to assist providers in reporting these services properly.

01/01/2021 R7

Article revised and published on 02/11/2021 effective for dates of service on and after 01/01/2021 to reflect the Annual HCPCS/CPT Code Updates.

The following HCPCS code has been added to the Group 1 CPT/HCPCS Codes group and to the ICD-10 Codes that Support Medical Necessity Group 1 Paragraph: J7212.

For the following HCPCS code either the short description and/or the long description was changed. Depending on which description is used in this article, there may not be any change in how the code displays: J7189.

07/01/2020 R6

Revision Number: 6
Publication: July 2020 Connection
LCR A/B2020-050

Explanation of Revision: Based on the July 2020 Quarterly Update, HCPCS code J7204 was added to the “CPT/HCPCS Codes/Group 6 Codes:” and “ICD-10 Codes that Support Medical Necessity/Group 6 Paragraph:” sections of this billing and coding article. The effective date of this revision is based on date of service.

07/01/2019 R5

12/06/2019:  The content in the Billing and Coding Article was revised to be consistent with the new format supported by CMS IOM Publication 100-08, Medicare Program Integrity Manual, Chapter 13, Section 13.5.1.

07/01/2019 R4

Moved HCPCS code J7208 from the “CPT/HCPCS Codes/Group 6 Paragraph:” section of the Billing and Coding Article to the “CPT/HCPCS Codes/Group 6 Codes:” section of the Billing and Coding Article.

07/01/2019 R3

Revision Number: 3
Publication: June 2019 Connection
LCR A/B2019-033

Explanation of Revision: Based on change requests (CRs) 11293, 11296, 11298, 11318, and 11328, HCPCS codes C9141 and J7199 were removed and replaced with HCPCS code J7208. The effective date of this revision is for dates of service on or after July 1, 2019. In addition, based on review of the Billing and Coding article, typographical and formatting errors were corrected. The effective date of this revision is based on date of service.

04/01/2019 R2

Moved HCPCS Code C9141 INJECTION, FACTOR VIII, (ANTIHEMOPHILIC FACTOR, RECOMBINANT), PEGYLATED-AUCL (JIVI) 1 I.U. from CPT/HCPCS Group 6 Paragraph to Group 6 Codes.

01/08/2019 R1

Corrected article text to add paragraph, and corrected paragraph for CPT/HCPCS group 1 and 2.

N/A

Associated Documents

Medicare BPM Ch 15.50.2 SAD Determinations
Medicare BPM Ch 15.50.2
Related National Coverage Documents
N/A
SAD Process URL 1
N/A
SAD Process URL 2
N/A
Statutory Requirements URLs
N/A
Rules and Regulations URLs
N/A
CMS Manual Explanations URLs
N/A
Other URLs
N/A
Public Versions
Updated On Effective Dates Status
09/29/2023 10/01/2023 - N/A Currently in Effect You are here
07/14/2023 07/01/2023 - 09/30/2023 Superseded View
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A